LCG
NXTM

Lisanti Capital Growth’s NxStage Medical Inc. NXTM Stock Holding History

Lisanti Capital Growth’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,470
Closed -$248K – 127
2016
Q4 		$248K Buy
+9,470
New +$234K 0.3% 89
2016
Q1 		– Sell
-49,295
Closed -$1.08M – 125
2015
Q4 		$1.08M Buy
+49,295
New +$919K 1.13% 43

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Lisanti Capital Growth's NXTM Position: Q1 2017 in Review

Lisanti Capital Growth sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 9,470 shares — an estimated $248K sold.

Lisanti Capital Growth first reported a position in NXTM in Q4 2015 and held it in 2 quarters. The position peaked at $1.08M in Q4 2015. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • Lisanti Capital Growth reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • Lisanti Capital Growth sold 9,470 NxStage Medical Inc. shares in Q1 2017, an estimated $248K.
  • Lisanti Capital Growth first reported a position in NxStage Medical Inc. in Q4 2015 and held it in 2 quarters.
  • Lisanti Capital Growth's NxStage Medical Inc. position peaked at $1.08M in Q4 2015.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Lisanti Capital Growth's 13F filing for Q1 2017, filed 12 May 2017.